Bayer’s adjusted EBITDA was 2. 51 billion euros in the third quarter, beating consensus of 2.307 billion euros. DAX Group now expects a turnover of 50.5 to 51.5 billion euros for the whole year (previously 50 to 51 billion euros). Adjusted profit per share is estimated at 7.70 euros. DZ Bank analysts consider 7.99 euros possible (previously: 7. 6 euros). In their new research, they confirm a buy recommendation on Bayer shares. The target price drops from EUR 76.00 to EUR 75.00. Inflation will have a negative impact on costs in the last quarter and also in 2023. In the pharmaceutical industry, this transfer to customers is likely to be limited. Analysts believe that the amount of glyphosate reserves (8 billion euros) should be enough. , shares of Bayer (WKN: BAY001, ISIN: DE000BAY0017, Kaavio ) are almost unchanged at €55. 5.